文献速递泌尿生殖USMR

前列腺穿刺活检:何时做与如何做

Prostate biopsy: when and how to perform.
PubMed 文献 · Clin Radiol · 2019-05-09

过去三十年前列腺癌采用非靶向系统穿刺取样,因取样体积小、对前部、外侧外周带及尖部取样不足,系统经直肠超声(TRUS)活检对临床显著前列腺癌敏感度低,增加穿刺针数后并发症和临床不显著癌检出增多。多参数磁共振成像(MRI)组织对比度高,催生MRI靶向活检(MRI-TRUS融合或直接机架内引导),可提高阳性针数百分比和临床显著前列腺癌检出,但费用高、耗时、需资本投入和操作者经验;本文阐述TRUS引导活检和MRI引导活检的适应证、工作流程、并发症及优缺点。

要点

  • 系统TRUS活检对临床显著前列腺癌敏感度低,前部、外侧外周带及尖部易漏检。
  • 增加穿刺针数并重点覆盖既往取样不足区域后,并发症发生率和临床不显著癌检出增加。
  • MRI靶向活检(融合或直接引导)可提高阳性针数百分比和临床显著前列腺癌检出。

核心结论

  • MRI靶向活检提高了阳性针数百分比和临床显著前列腺癌的检出,但费用高、耗时、需大量资本投入和操作者经验。

研究设计与样本

  • 本文为综述,描述TRUS引导活检和MRI引导活检的适应证、工作流程、并发症及优缺点。

临床应用与阅片要点

  • 系统TRUS活检需关注前部、外侧外周带及尖部等既往取样不足或漏检区域。
  • MRI靶向活检可采用MRI-TRUS融合或直接(机架内)引导两种方式。

局限性

  • MRI靶向活检费用高、耗时、需大量资本投入和操作者经验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Prostate cancer, unlike other cancers, has been sampled in a non-targeted, systematic manner in the past three decades. On account of the low volume of prostate sampled despite the multiple cores acquired, systematic transrectal (TRUS) biopsy suffered from low sensitivity in picking up clinically significant prostate cancer. In addition, a significant number of cancers of the anterior, lateral peripheral zone, and the apex were missed as these areas were undersampled or missed during this biopsy protocol. Subsequently, the number of cores acquired was increased with special focus given to targeting the previously undersampled areas. These procedures led to an increase in the complication rates as well as detection of more clinically insignificant cancers. The advent of multiparametric magnetic resonance imaging (MRI) and its high intrinsic tissue contrast enabled better detection of prostate cancer. This led to the introduction of MRI-targeted biopsies with either MRI-TRUS fusion or under direct (in-gantry) guidance. MRI-targeted biopsies increased the percentage of positive cores and detection of clinically significant prostate cancers; however, these are expensive, time-intensive, require significant capital investment and operator expertise. This article describes the indications, workflow, complications, advantages, and disadvantages of TRUS-guided biopsy followed by MRI-guided biopsies.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Das CJ, Razik A, Sharma S, et al. Prostate biopsy: when and how to perform. Clin Radiol. 2019. PMID: 31079953. doi:10.1016/j.crad.2019.03.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。